Table 3 Characteristics of studies included for comparative data and comparison of average prescribing rates per 1000 GMS children between 2001 and 2011, to European rates per 1000 children
Study (publication year) | Country (year data represents) | Sample Size | Age | Overall Rate of Anti-depressant Prescribing (per 1000) | Setting |
|---|---|---|---|---|---|
Dorks (2013) [23] | Germany (2004–2006) | 2 599 685 | 0–17 | 1.7/1000 | Pharmaco-epidemiology database |
Volkers (2007) [24] | Netherlands (2001–2005) | 350 000 | 0–17 | 2.2/1000 | Information Network of General Practice |
Wijlaars (2012) [12] | UK (1995–2009) | 1 502 753 | 0–17 | 3.6/1000 | UK primary care database |
Parkinson (2012) [25] | US (2002–2005) | 32 111 | 0–17 | 8.77/1000 | Medical Expenditure Panel survey |
Steinhausen (2014) [26] | Denmark (1996–2010) | 105 908 | 0–17 | 1.6/1000 | National Patient Database |
GMS data | Ireland (2002 – 2011) | 311 579 | 0–15 | 3.3/1000 | Primary care reimbursement service pharmacy claims |